Newsroom

Recent News Releases

June 26, 2017 Jun 26, 2017 Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS^® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

June 26, 2017 Jun 26, 2017 Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines for Low- and Middle-Income Countries around the Globe

June 23, 2017 Jun 23, 2017 Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

June 23, 2017 Jun 23, 2017 Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA

June 16, 2017 Jun 16, 2017 Takeda Announces Completion of New Manufacturing Facilities at the Oranienburg Site in Germany

SEE ALL NEWS AND RELEASES >

Featured Topics

Micro Size, Macro Opportunity: Looking for New Applications of our Microbiome
LEARN MORE

Leveraging the Superpowers of People Living with IBD to Create the First IBD Super Hero Team
LEARN MORE

FOR MORE TOPICS>

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.